Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

May 1, 2012

View Archives Issues

  • Ivermectin Lotion 0.5% (Sklice™)

    A new topical preparation for the treatment of head lice has been approved by the FDA. Ivermectin is a macrocyclic lactone antibiotic that has been used orally both on and off label for head lice since 2001.
  • Myocardial Infarction Symptom Presentation

    Timely recognition and treatment of myocardial infarction (MI) are crucial if we are to achieve optimal outcomes for our patients. Silent ischemia, or the absence of classical symptoms of ischemia, may delay the diagnosis.
  • The problem with C difficile Infection

    This report attempts to catalogue the ballooning number of cases of C difficile infection (CDI) in the United States using available resources, including data collected from the IDSA Emerging Infections Program (which has a catchment area of 111 acute-care hospitals and 310 nursing homes); the 2010 National Health and Safety Network data, which covers 711 acute care hospitals in 28 States; and data derived from 3 CDI prevention programs in 3 different states.
  • ID drug shortages threaten patient safety

    Recent efforts to treat a patient in hospital with acute pneumocystis pneumonia (PCP) were hampered by a lack of available injectable trimethoprim-sulfamethoxazole.